financetom
Business
financetom
/
Business
/
Olema Pharmaceuticals Proposes Public Offering of Shares, Pre-Funded Warrants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Olema Pharmaceuticals Proposes Public Offering of Shares, Pre-Funded Warrants
Nov 18, 2025 6:00 PM

05:34 PM EST, 11/18/2025 (MT Newswires) -- Olema Pharmaceuticals ( OLMA ) announced late Tuesday its plans for a public offering of common stock and pre-funded warrants.

The company said underwriters will have a 30-day option to purchase an additional 15% of the shares, including those underlying the pre-funded warrants.

Olema added that there is no assurance regarding the timing, size, or completion of the proposed offering.

Shares of the company were down 2.4% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Orthofix beats Q3 sales estimates, narrows FY forecast
Orthofix beats Q3 sales estimates, narrows FY forecast
Nov 4, 2025
Overview * Orthofix Q3 net sales rose 5% yr/yr to $205.6 mln, beating analyst expectations * Adjusted EBITDA for Q3 increased 28.2% yr/yr, beating analyst estimates * Company narrowed full-year net sales guidance, raised low end of adjusted EBITDA guidance Outlook * Orthofix narrows 2025 net sales guidance to $810 mln-$814 mln * Orthofix raises low end of 2025 adjusted...
Taysha Gene Therapies Q3 net loss widens as R&D costs rise
Taysha Gene Therapies Q3 net loss widens as R&D costs rise
Nov 4, 2025
Overview * Taysha reports bigger Q3 net loss of $32.7 mln, with increased R&D expenses * TSHA-102 granted FDA Breakthrough Therapy designation for Rett syndrome * Company regained full rights to TSHA-102 Rett syndrome program in October Outlook * Company plans to dose first patient in REVEAL trial in Q4 2025 * Taysha expects additional patient enrollment at multiple sites...
Algoma Central Corp Q3 revenue up 11.4%
Algoma Central Corp Q3 revenue up 11.4%
Nov 4, 2025
Overview * Algoma Q3 2025 revenue rises to C$228,035, reflecting growth across key segments * EBITDA for Q3 2025 increases to C$89,739 from C$75,696 in 2024 * Company marks milestone with delivery of 100th vessel, Algoma Legacy Outlook * Algoma expects strong fleet utilization in Domestic Dry-Bulk due to spot demand and salt volumes * Product Tanker segment demand expected...
Anywhere Real Estate Q3 revenue misses estimates
Anywhere Real Estate Q3 revenue misses estimates
Nov 4, 2025
Overview * Anywhere Q3 revenue increased 6% to $1.6 bln, missing analyst expectations * Net loss for Q3 was $13 mln, a decline of $20 mln yr/yr * Anywhere announces merger with Compass, closing expected in 2026 Outlook * Company suspends forward guidance due to proposed merger with Compass * Anywhere Real Estate expects merger with Compass to close in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved